UNSPSC 85445603: The diagnosis of ganglionic blocking drugs

In this classification, this covers the group of activities that yields a diagnosis of ganglionic blocking drugs, not elsewhere classified. Ganglionic blocking drugs, not elsewhere classified is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y51.2.

UNSPSC 85445603, diagnosis of ganglionic blocking drugs, is a Commodity code that shows a notable mismatch between its nominal scope and recent state and local procurement activity — the code's pharmaceutical focus does not align with the actual work being solicited under it. The three most recent opportunities tagged to this code are a diagnostic imaging PACS (Picture Archiving and Communication System) implementation at a county hospital, special education contracted services across a school district, and temporary health professional staffing services across a county health system. None of these solicitations involve ganglionic blocking drugs or pharmaceutical procurement. The code appears to reflect a misclassification or data-entry error rather than genuine procurement activity in the pharmacological domain.

State and local activity under this code is currently limited to health system and education issuing bodies in California and Texas. San Mateo Medical Center in San Mateo County, California posted an RFP (due October 21, 2026) for enterprise-grade diagnostic imaging PACS implementation with EPIC integration, 99.9% uptime requirements, and migration of approximately 78,000 annual studies from a legacy system. Birdville Independent School District in northeast Tarrant County, Texas solicited competitive sealed proposals (due October 21, 2026) for 23 line items of special education contracted services including audiologists, diagnosticians, and therapists across 30 campuses. The County of Santa Clara Health System in California posted a non-exclusive, multiple-award RFQ (due October 7, 2026) to establish a qualified vendor pool for temporary health professional staffing across 13 ancillary clinical categories. Given the absence of relevant recent opportunities under the code's stated pharmaceutical scope, this code warrants monitoring rather than active pursuit until procurement activity aligns with ganglionic blocking drug applications.